Search

Nicholas R Bachur

from Monkton, MD
Age ~72
Get Report
Also known as:
Nickolas R Bachur
Phone and address:
750 Monkton Rd, Hereford, MD 21111
Related to:
Alexander C Ceballos, 44Cynthia R, 72Ruth LangCynthia Bachur, 72Edmund Lang
Connected to:
Kipp J Bachurski, 60Dean C Bachus, 51Jacqueline B Bachus, 60Lee A Bachus, 66Timothy Bachus, 55Toni L Bachus, 76Patrick J Bachuwa, 52Nikolay K Bachvarov, 48Dale R Bachwich, 63Natalie E Bachynsky, 49

Nicholas Bachur Phones & Addresses

  • 750 Monkton Rd, Monkton, MD 21111
  • Baltimore, MD

Professional Records

Medicine Doctors

Nicholas Bachur Photo 1

Nicholas Robert Bachur, Towson MD

View page
Specialties:
Clinical Pharmacology
Critical Care Medicine
Work:
Private Pracrice
709 Thornwood Ct, Towson, MD 21286
Education:
University of Maryland(1961)

License Records

Nicholas Robert Bachur

Address:
750 Monkton Rd, Monkton, MD 21111
License #:
A0068953
Category:
Airmen

Business Records

Name / Title
Company / Classification
Phones & Addresses
Nicholas Bachur
Professor
University of Maryland
College/University · University
655 W Baltimore St, Baltimore, MD 21201
(410) 706-4852, (410) 706-3100
Nicholas Robert Bachur
Nicholas Bachur MD
Pharmacy · Internist
709 Thornwood Ct, Towson, MD 21286
(301) 828-7009
Nicholas Bachur
Professor
University of Maryland, College Park
Colleges and Universities
2181 Glenn Martin Hall, College Park, MD 20742
(301) 405-1000

Publications

Us Patents

Automated Microbiological Testing Apparatus And Method Therefor

View page
US Patent:
6372485, Apr 16, 2002
Filed:
May 17, 2000
Appl. No.:
09/572078
Inventors:
Alexander W. Clark - Baltimore MD
Paul Gladnick - Seattle WA
Robert E. Armstrong - Hunt Vally MD
Nicholas Bachur - Monkton MD
Klaus W. Berndt - Timonium MD
Dwight Livingston - Fallston MD
Assignee:
Becton Dickinson and Company - Franklin Lakes NJ
International Classification:
C12M 134
US Classification:
4352887, 4352874, 435808, 422 8205, 356317, 356432, 356213
Abstract:
A diagnostic microbiological testing system and method for microorganism identification (ID) and antimicrobial susceptibility determinations (AST). The system includes multiple-well test panels capable of performing ID and AST testing on the same test panel. Each test panel is inoculated with reagents, broth-suspended organisms, and placed into the instrument system. The instrument system includes a rotating carousel for incubation and indexing, multiple light sources each emitting different wavelength light, precision calorimetric and fluorometric detection, barcode test panel tracking and a control processor for making determinations based on measured test data. One light source includes a plurality of LEDs arranged in a linear array. Each of the LEDs junction currents are controllable to produce a predetermined illumination profile.

Automated Microbiological Testing Apparatus And Method Therefor

View page
US Patent:
7115384, Oct 3, 2006
Filed:
Jan 28, 2002
Appl. No.:
10/056028
Inventors:
Alexander W. Clark - Baltimore MD, US
Paul Gladnick - Seattle WA, US
Robert E. Armstrong - Hunt Vally MD, US
Nicholas Bachur - Monkton MD, US
Klaus W. Berndt - Timonium MD, US
Dwight Livingston - Fallston MD, US
Assignee:
Becton Dickinson and Company - Franklin Lakes NJ
International Classification:
C12Q 1/02
US Classification:
435 29, 435 31, 4352862, 4352873, 4352887, 422 64
Abstract:
A diagnostic microbiological testing system and method for microorganism identification (ID) and antimicrobial susceptibility determinations (AST). The system includes multiple-well test panels capable of performing ID and AST testing on the same test panel. Each test panel is inoculated with reagents, broth-suspended organisms, and placed into the instrument system. The instrument system includes a rotating carousel for incubation and indexing, multiple light sources each emitting different wavelength light, precision calorimetric and fluorometric detection, barcode test panel tracking and a control processor for making determinations based on measured test data. One light source includes a plurality of LEDs arranged in a linear array. Each of the LEDs' junction currents are controllable to produce a predetermined illumination profile.

System And Method For Optically Monitoring The Concentration Of A Gas In A Sample Vial Using Photothermal Spectroscopy To Detect Sample Growth

View page
US Patent:
20020197708, Dec 26, 2002
Filed:
Jun 26, 2001
Appl. No.:
09/892012
Inventors:
Nicholas Bachur - Monkton MD, US
International Classification:
C12M001/34
US Classification:
435/287500, 435/288700
Abstract:
A system and method for monitoring the concentration of a medium in at least one container using photothermal spectroscopy. The medium can be a gas, such as oxygen or carbon dioxide, or a solid or liquid. The system and method each employs an energy emitting device, such as a laser or any other suitable type of light emitting device, which is adapted to emit a first energy signal toward a location in the container. The first energy signal has a wavelength that is substantially equal to a wavelength at which the medium absorbs the first energy signal so that absorption of the first energy signal changes a refractive index of a portion of the medium. The system and method each also employs a second energy emitting device, adapted to emit a second energy signal toward the portion of the medium while the refractive index of the portion is changed by the first energy signal, and a detector, adapted to detect a portion of the second energy signal that passes through the portion of the medium. The system and method each further employs a signal analyzer, adapted to analyze the detected portion of the second energy signal to determine an amount of a sample in the container based on a concentration of the medium in the container. In particular, the signal analyzer can analyze the detection portion of the second energy signal to determine whether the sample includes an organism which consumes or emits the medium.

System And Method For Optically Monitoring The Concentration Of A Gas, Or The Pressure, In A Sample Vial To Detect Sample Growth

View page
US Patent:
20030111607, Jun 19, 2003
Filed:
Jun 26, 2001
Appl. No.:
09/892061
Inventors:
Nicholas Bachur - Monkton MD, US
Patrick Beaty - Felton PA, US
Timothy Foley - Forest Hill MD, US
International Classification:
G01N021/84
US Classification:
250/343000, 435/034000
Abstract:
A system and method employing infrared laser spectrography and dual wavelength modulation to monitor the concentration of a gas, such as oxygen or carbon dioxide, in the sample vial, or to monitor the pressure in the sample vial, to thus detect for microorganism growth in the sample vial. The system and method each employ an energy emitting device, such as an infrared laser, a detector and a signal analyzer, such as a spectroscopy device. The infrared laser emits toward the container infrared energy having a substantially single wavelength substantially equal to a wavelength at which the gas absorbs the infrared energy. The detector detects a portion of the energy signal that passes through the container, and the signal analyzer spectroscopically analyzes the detected portion of the energy signal to determine whether the gas exists in the container, or to determine the pressure in the container. The system and method thus determines whether an organism or cell of interest is present or viable in the container based on the results of the gas or pressure detection.

Rapid Imaging Of Particles In A Large Fluid Volume Through Flow Cell Imaging

View page
US Patent:
20030133119, Jul 17, 2003
Filed:
Jan 17, 2002
Appl. No.:
10/047985
Inventors:
Nicholas Bachur - Monkton MD, US
International Classification:
G01N021/00
US Classification:
356/436000
Abstract:
The present invention provides a method of and an apparatus for the rapid imaging of particles such as, for example, cells, in a flow volume. The present invention enables convenient, automated analysis of particles in a two-dimensional imaged frame confined by the walls of a thin, transparent, three-dimensional flow cell.

System And Method For Optically Monitoring The Concentration Of A Gas In A Sample Vial Using Photothermal Spectroscopy To Detect Sample Growth

View page
US Patent:
20040086956, May 6, 2004
Filed:
Dec 5, 2003
Appl. No.:
10/728548
Inventors:
Nicholas Bachur - Monkton MD, US
International Classification:
C12M001/34
US Classification:
435/034000, 435/287500, 435/288700
Abstract:
A system and method for monitoring the concentration of a medium in at least one container using photothermal spectroscopy. The medium can be a gas, such as oxygen or carbon dioxide, or a solid or liquid. The system and method each employs an energy emitting device, such as a laser or any other suitable type of light emitting device, which is adapted to emit a first energy signal toward a location in the container. The first energy signal has a wavelength that is substantially equal to a wavelength at which the medium absorbs the first energy signal so that absorption of the first energy signal changes a refractive index of a portion of the medium. The system and method each also employs a second energy emitting device, adapted to emit a second energy signal toward the portion of the medium while the refractive index of the portion is changed by the first energy signal, and a detector, adapted to detect a portion of the second energy signal that passes through the portion of the medium. The system and method each further employs a signal analyzer, adapted to analyze the detected portion of the second energy signal to determine an amount of a sample in the container based on a concentration of the medium in the container. In particular, the signal analyzer can analyze the detection portion of the second energy signal to determine whether the sample includes an organism which consumes or emits the medium.

Diagnosis Of Sepsis Or Sirs Using Biomarker Profiles

View page
US Patent:
20040096917, May 20, 2004
Filed:
Nov 12, 2003
Appl. No.:
10/704899
Inventors:
Richard Ivey - Parkton MD, US
Thomas Gentle - Red Lion PA, US
Richard Moore - Glenville PA, US
Michael Towns - Timonium MD, US
Nicholas Bachur - Monkton MD, US
Robert Rosenstein - Ellicott City MD, US
James Nadeau - Ellicott City MD, US
Paul Goldenbaum - Hampstead MD, US
Song Shi - Reisterstown MD, US
Donald Copertino - Catonsville MD, US
James Garrett - Baltimore MD, US
Gregory Tice - Lutherville MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
G01N033/554
G01N033/569
US Classification:
435/007320
Abstract:
The early prediction or diagnosis of sepsis advantageously allows for clinical intervention before the disease rapidly progresses beyond initial stages to the more severe stages, such as severe sepsis or septic shock, which are associated with high mortality. Early prediction or diagnosis is accomplished by comparing an individual's profile of biomarker expression to profiles obtained from one or more control, or reference, populations, which may include a population that develops sepsis. Recognition of features in the individual's biomarker profile that are characteristic of the onset of sepsis allows a clinician to diagnose the onset of sepsis from a bodily fluid isolated from the individual at a single point in time. The necessity of monitoring the patient over a period of time is, therefore, avoided, advantageously allowing clinical intervention before the onset of serious symptoms of sepsis. Further, because the biomarker expression is assayed for its profile, identification of the particular biomarkers is unnecessary. The comparison of an individual's biomarker profile to biomarker profiles of appropriate reference populations likewise can be used to diagnose SIRS in the individual.

Diagnosis Of Sepsis Or Sirs Using Biomarker Profiles

View page
US Patent:
20040097460, May 20, 2004
Filed:
Nov 12, 2003
Appl. No.:
10/704661
Inventors:
Richard Ivey - Parkton MD, US
Thomas Gentle - Red Lion PA, US
Richard Moore - Glenville PA, US
Michael Towns - Timonium MD, US
Nicholas Bachur - Monkton MD, US
Robert Rosenstein - Ellicott City MD, US
Paul Goldenbaum - Hampstead MD, US
Song Shi - Reisterstown MD, US
Donald Copertino - Catonsville MD, US
James Garrett - Baltimore MD, US
Gregory Tice - Lutherville MD, US
Assignee:
Becton, Dickinson and Company - Franklin Lakes NJ
International Classification:
A61K048/00
C12Q001/68
US Classification:
514/044000, 435/006000
Abstract:
The early prediction or diagnosis of sepsis advantageously allows for clinical intervention before the disease rapidly progresses beyond initial stages to the more severe stages, such as severe sepsis or septic shock, which are associated with high mortality. Early prediction or diagnosis is accomplished using a molecular diagnostics approach, involving comparing an individual's profile of biomarker expression to profiles obtained from one or more control, or reference, populations, which may include a population that develops sepsis. Recognition of features in the individual's biomarker profile that are characteristic of the onset of sepsis allows a clinician to diagnose the onset of sepsis from a bodily fluid isolated at the individual at a single point in time. The necessity of monitoring the patient over a period of time is, therefore, avoided, advantageously allowing clinical intervention before the onset of serious symptoms of sepsis. Further, because the biomarker expression is assayed for its profile, identification of the particular biomarkers is unnecessary. The comparison of an individual's biomarker profile to biomarker profiles of appropriate reference populations likewise can be used to diagnose SIRS in the individual.
Control profile
Nicholas R Bachur from Monkton, MD, age ~72 Get Report